Overview
Victor Adorno is an Oncologist in New York, New York. Dr. Adorno is highly rated in 8 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Upper Tract Urothelial Carcinoma (UTUC), and Chromophobe Renal Cell Carcinoma.
His clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
550 1st Ave, New York, NY 10016
111 Broadway, New York, NY 10006
160 E 34th St, New York, NY 10016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Memorial Hematology Lymphoma Group
Steven Horwitz is an Oncologist in New York, New York. Dr. Horwitz is highly rated in 25 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration.
Memorial Solid Tumor Group
Sandra Dangelo is an Oncologist in New York, New York. Dr. Dangelo is highly rated in 33 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Synovial Sarcoma, Merkel Cell Carcinoma, Liposarcoma, and Liver Embolization.
Memorial Hematology Lymphoma Group
Andrew Zelenetz is an Oncologist in New York, New York. Dr. Zelenetz is highly rated in 22 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Diffuse Large B-Cell Lymphoma (DLBCL).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Adorno isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Adorno isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Adorno isAdvanced. Learn about Familial Wilms Tumor 2.
- Renal Cell Carcinoma (RCC)Dr. Adorno isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerDr. Adorno isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Adorno isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Adorno isExperienced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Adorno isExperienced. Learn about Choriocarcinoma.
- Familial Prostate CancerDr. Adorno isExperienced. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Adorno isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Adorno isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.